Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:: are we ready for a prognostically prioritized molecular classification?

被引:438
作者
Mrozek, Krzysztof
Marcucci, Guido
Paschka, Peter
Whitman, Susan P.
Bloomfield, Clara D.
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Div Human Canc Genet, Dept Microbiol Virol Immunol & Med Genet, Columbus, OH 43210 USA
关键词
D O I
10.1182/blood-2006-06-001149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent molecular analyses of leukemic blasts from pretreatment marrow or blood of patients with acute myeloid leukemia (AML) and a normal karyotype, the largest cytogenetic subset (ie, 40%-49%) of AML, have revealed a striking heterogeneity with regard to the presence of acquired gene mutations and changes in gene expression. Multiple submicroscopic genetic alterations with prognostic significance have been discovered, including internal tandem duplication of the FLT3 gene, mutations in the NPM1 gene, partial tandem duplication of the MLL gene, high expression of the BAALC gene, and mutations in the CEBPA gene. Application of gene-expression profiling has also identified a gene-expression signature that appears to separate cytogenetically normal AML patients into prognostic subgroups, although gene-expression signature-based classifiers predicting outcome for individual patients with greater accuracy are needed. These and similar future findings are likely to have a major impact on the clinical management of cytogenetically normal AML not only in prognostication but also in selection of appropriate treatment, since many of the identified genetic alterations already constitute or will potentially become targets for specific therapeutic intervention. In this report, we review prognostic genetic findings in karyotypically normal AML and discuss their clinical implications.
引用
收藏
页码:431 / 448
页数:18
相关论文
共 106 条
[1]   FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group [J].
Abu-Duhier, FM ;
Goodeve, AC ;
Wilson, GA ;
Gari, MA ;
Peake, IR ;
Rees, DC ;
Vandenberghe, EA ;
Winship, PR ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :190-195
[2]  
[Anonymous], CLIN PRACT GUID ONC
[3]   Implications of NRAS mutations in AML:: a study of 2502 patients [J].
Bacher, Ulrike ;
Haferlach, Torsten ;
Schoch, Claudia ;
Kern, Wolfgang ;
Schnittger, Susanne .
BLOOD, 2006, 107 (10) :3847-3853
[4]  
Bacher U, 2005, HAEMATOLOGICA, V90, P1502
[5]   BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics:: Prognostic implications [J].
Baldus, CD ;
Thiede, C ;
Soucek, S ;
Bloomfield, CD ;
Thiel, E ;
Ehninger, G .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) :790-797
[6]   Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21:: Amplification discloses overexpression of APP, ETS2, and ERG genes [J].
Baldus, CD ;
Liyanarachchi, S ;
Mrózek, K ;
Auer, H ;
Tanner, SM ;
Guimond, M ;
Ruppert, AS ;
Mohamed, N ;
Davuluri, RV ;
Caligiuri, MA ;
Bloomfield, CD ;
de la Chapelle, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3915-3920
[7]   BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:: a Cancer and Leukemia Group B Study [J].
Baldus, CD ;
Tanner, SM ;
Ruppert, AS ;
Whitman, SP ;
Archer, KJ ;
Marcucci, G ;
Caligiuri, MA ;
Carroll, AJ ;
Vardiman, JW ;
Powell, BL ;
Allen, SL ;
Moore, JO ;
Larson, RA ;
Kolitz, JE ;
de la Chapelle, A ;
Bloomfield, CD .
BLOOD, 2003, 102 (05) :1613-1618
[8]  
Barragán E, 2004, HAEMATOLOGICA, V89, P926
[9]   FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype [J].
Beran, M ;
Luthra, R ;
Kantarjian, H ;
Estey, E .
LEUKEMIA RESEARCH, 2004, 28 (06) :547-550
[10]  
Bienz M, 2005, CLIN CANCER RES, V11, P5659